Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Merlob

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2005
Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative studyBenjamin Bar-Oz, Maurizio Clementi, Elena Di Giantonio, et al.
Pediatric Dermatology|October 15, 2011
New syndrome of congenital circumferential skin folds associated with multiple congenital anomaliesLina Basel-Vanagaite, Eli Sprecher, Andrea Gat, et al.
American Journal of Perinatology|October 3, 2002
Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international studyMatitiahu Berkovitch, Paul Mazzota, Revital Greenberg, et al.
Thrombosis and Haemostasis|May 30, 2006
Vitamin K antagonists and pregnancy outcome. A multi-centre prospective studyChristof Schaefer, Doreen Hannemann, Reinhard Meister, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Journal of Clinical Psychopharmacology|April 2, 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective studyUrsula Winterfeld, Gil Klinger, Alice Panchaud, et al.
Drug Safety|June 19, 2012
The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational studyBenjamin Bar-Oz, Corinna Weber-Schoendorfer, Maya Berlin, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 30, 2010
Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and researchAlessandra Lisi, Lorenzo D Botto, Elisabeth Robert-Gnansia, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 8, 2005
Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information ServicesHanneke Garbis, Elisabeth Elefant, Orna Diav-Citrin, et al.
Neurology|May 20, 2016
Pregnancy outcome following maternal exposure to pregabalin may call for concernUrsula Winterfeld, Paul Merlob, David Baud, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 6, 2005
Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative studyBenjamin Bar-Oz, Maurizio Clementi, Elena Di Giantonio, et al.
Pediatric Dermatology|October 15, 2011
New syndrome of congenital circumferential skin folds associated with multiple congenital anomaliesLina Basel-Vanagaite, Eli Sprecher, Andrea Gat, et al.
American Journal of Perinatology|October 3, 2002
Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international studyMatitiahu Berkovitch, Paul Mazzota, Revital Greenberg, et al.
Thrombosis and Haemostasis|May 30, 2006
Vitamin K antagonists and pregnancy outcome. A multi-centre prospective studyChristof Schaefer, Doreen Hannemann, Reinhard Meister, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Journal of Clinical Psychopharmacology|April 2, 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective studyUrsula Winterfeld, Gil Klinger, Alice Panchaud, et al.
Drug Safety|June 19, 2012
The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational studyBenjamin Bar-Oz, Corinna Weber-Schoendorfer, Maya Berlin, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 30, 2010
Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and researchAlessandra Lisi, Lorenzo D Botto, Elisabeth Robert-Gnansia, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 8, 2005
Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information ServicesHanneke Garbis, Elisabeth Elefant, Orna Diav-Citrin, et al.
Neurology|May 20, 2016
Pregnancy outcome following maternal exposure to pregabalin may call for concernUrsula Winterfeld, Paul Merlob, David Baud, et al.
Pageof 8